SAMDI Tech is looking forward to attending Label-Free Mass Spectrometry Assays for Early Drug Discovery at Panoramazaal at Pivot Park, Netherlands on January 25, 2023. This one-day only symposium will highlight the recent advances and applications of label-free high-throughput cell-based and affinity-selection mass spectrometry (MS) screening assay technologies as an emerging lead discovery strategy.
Join CSO, Dr. Zack Gurard-Levin for a presentation on addressing the current challenge of cumbersome sample prep procedures of label-free analysis of biochemical activities. Dr. Gurard-Levin will present the application of SAMDI in an ASMS format to screen and characterize candidate molecular glues, and describe how the development of a duplexed assay was used to simultaneously measure and distinguish tyrosine and threonine phosphatase activities from cells.
Wednesday, January 25
3:10 p.m. CET
From analyzing purified targets to cells: Combining surface chemistry and MALDI MS to analyze biochemical and binding reactions
Want to learn more? Fill out the form to schedule a meeting and discuss how SAMDI Tech can provide solutions to all of your drug discovery needs!
We hope to see you there!